Virtual Medicinal Product (VMP)
-
Mesalazine 1g/application foam enema
Name Details
Current Name
Mesalazine 1g/application foam enema
|
Start Date
14-04-2004
|
End Date
|
Previous Name
Mesalazine 1g/application foam enemas
|
Start Date
06-03-2003
|
End Date
13-04-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- application
- Unit Dose UOM
- application
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Rectal
- Form
- Rectal foam
- Ontology Form/Route
- foamenema.rectal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A07EC02
BNF |
Current BNF
01050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
01050100
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
01050000
|
Start Date
02-02-2005
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36565211000001100 |
17-01-2019 |
|
317410005 |
06-03-2003 |
16-01-2019 |
VMP Ingredients
VMP ingredients table
Mesalazine |
Based on Ingredient Substance |
|
1 gram |
1 application |
Name
Mesalazine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Mesalazine
-
VMP
(Current) Mesalazine 1g/application foam enema
Virtual Medicinal Product Pack (VMPP) Information